Related Experiment Video
Updated: Jan 19, 2026

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
Published on: July 18, 2017
Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in
Rita Sala1, Laura Sánchez-García2, Naroa Serna2
1CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Institut d'Investigacions Biomèdiques Sant Pau and Josep Carreras Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Abstract:
By the appropriate selection of functional peptides and proper accommodation sites, we have generated a set of multifunctional proteins that combine selectivity for CXCR4+ cell binding and relevant endosomal escape capabilities linked to the viral peptide HA2. In particular, the construct T22-GFP-HA2-H6 forms nanoparticles that upon administration in mouse models of human, CXCR4+ colorectal cancer, accumulates in primary tumor at levels significantly higher than the parental T22-GFP-H6 HA2-lacking version. The in vivo application of a CXCR4 antagonist has confirmed the prevalence of the CXCR4+ tumor tissue selectivity over unspecific cell penetration, upon systemic administration of the material. Such specificity is combined with improved endosomal escape, what overall results in a precise and highly efficient tumor biodistribution. These data strongly support the functional recruitment as a convenient approach to generate protein materials for clinical applications. More precisely, they also support the unexpected concept that enhancing the unspecific membrane activity of a protein material does not necessarily compromise, but it can even improve, the selective cell targeting offered by an accompanying functional module. STATEMENT OF SIGNIFICANCE: We have shown here that the combination of cell-penetrating and tumor cell-targeting peptides dramatically enhances precise tumor accumulation of protein-only nanoparticles intended for selective drug delivery, in mouse models of human colorectal cancer. This fact is a step forward for the rational design of multifunctional protein nanomaterials for improved cancer therapies.
Insights
Researchers created multifunctional protein nanoparticles that precisely target and accumulate in CXCR4-positive colorectal tumors. This approach enhances drug delivery and cancer therapy by combining cell targeting with improved endosomal escape.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- Targeted drug delivery systems are crucial for effective cancer therapy.
- Multifunctional protein nanoparticles offer potential for precise tumor targeting and enhanced therapeutic efficacy.
Purpose of the Study:
- To engineer multifunctional protein nanoparticles combining CXCR4-positive cell binding and endosomal escape capabilities.
- To evaluate the in vivo tumor accumulation and biodistribution of these nanoparticles in colorectal cancer models.
Main Methods:
- Constructing protein nanoparticles with specific functional peptides (T22, HA2) and a reporter (GFP).
- Administering nanoparticles to mouse models of human CXCR4-positive colorectal cancer.
- Utilizing CXCR4 antagonists to confirm tumor selectivity.
Main Results:
- Engineered nanoparticles demonstrated significantly higher accumulation in primary tumors compared to control versions.
- CXCR4-positive tumor tissue selectivity was confirmed in vivo.
- Enhanced endosomal escape contributed to precise and efficient tumor biodistribution.
Conclusions:
- Functional peptide recruitment is a viable strategy for creating protein materials for clinical applications.
- Enhancing non-specific membrane activity can improve, not compromise, selective cell targeting.
- These findings advance the rational design of protein nanomaterials for improved cancer therapies.
More Related Videos
10:16Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
04:08Intracecal Tumor Cell Injection: A Technique to Deliver Cancer Cells for Establishing Orthotopic Colorectal Cancer Mouse Model
Published on: April 30, 2023
Related Concept Videos
06:19Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
04:08Intracecal Tumor Cell Injection: A Technique to Deliver Cancer Cells for Establishing Orthotopic Colorectal Cancer Mouse Model
10:16Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
02:53Functionalized Nanoparticle Targeting of Ovarian Cancer: A Technique to Facilitate Folic Acid-conjugated Nanoparticle Contrast Agent Uptake by Ovarian Cancer Cells
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts